Talk: Integrating acupuncture into conventional cancer treatment, a practice model at Dana-Farber Cancer Institute

Weidong Lu, MB, MPH, PhD is an Oncology Acupuncturist and the Oncology Acupuncture Team Leader at Leonard P. Zakim Center for Integrative Therapies, Dana-Farber Cancer Institute (DFCI), a U.S. top cancer hospital and a principal teaching affiliate of Harvard Medical School. He is a principal investigator at Dana-Farber /Harvard Cancer Center and the lead investigator of Chinese Medicine Research Initiative at DFCI. He is Instructor in Medicine at Harvard Medical School and a Professor of Chinese Medicine at the New England School of Acupuncture in Newton, Massachusetts. He also chairs the Committee On Acupuncture at the Massachusetts Board of Registration in Medicine. He is the past chairman of Chinese Herbal Medicine Department at the New England School of Acupuncture. He holds a M.B. from Zhejiang Chinese Medical University, a MPH from Harvard School of Public Health and a PhD in Integrative Medicine from Beijing University of Chinese Medicine.
Dr. Weidong Lu created and established the Oncology Acupuncture Specialty at DFCI since 2000. He leads a team of five Oncology Acupuncturists. In addition to his clinical practice, he is a principal investigator conducting NIH-funded acupuncture clinical trials in symptom management for cancer patients. He is the first recipient of the Bernard Osher Foundation/ The National Center for Complementary and Alternative Medicine ( NCCAM ) CAM Practitioner Research Career Development Award. He is a member of the Research Committee of the Society for Integrative Oncology (SIO), and a member of the American Society of Clinical Oncology (ASCO). He is a faculty member of Harvard Medical School Research Fellowship Program in Integrative Medicine. He also lectured in the Freshman Seminar at Harvard University and the Oncology Fellowship Program at DFCI. He dedicates his research in Integrative Medicine, especially in Integrative Oncology. His research focuses on the creation and clinical practice of Oncology Acupuncture Specialty; clinical research on symptom management and supportive care using integrative medicine including acupuncture and Chinese herbal medicine; Drug-herbal interactions and the impacts on clinical practice; designing and conducting clinical trials of oncology acupuncture. He has published over 30 research papers and book chapters in peer-reviewed journals and he has been invited to speak internationally.